EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Therapeutic exploitation of ferroptosis

Magali Walravens, Ine Koeken, Tom Vanden Berghe iD

Biochemical Society Transactions · 2024

DOI: 10.1042/bst20230550 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, 2024. Verfasst von Magali Walravens und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium. Hauptthemen laut MEDLINE: Ferroptosis, Lipid Peroxidation, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 122 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathological breakdown of membrane lipids through excessive lipid peroxidation (LPO) was first described in the mid-20th century and is now recognized as a form of regulated cell death, dubbed ferroptosis. Accumulating evidence unveils how metabolic regulation restrains peroxidation of phospholipids within cellular membranes, thereby impeding ferroptosis execution. Unleashing these metabolic breaks is currently therapeutically explored to sensitize cancers to ferroptosis inducing anti-cancer therapies. Reversely, these natural ferroptotic defense mechanisms can fail resulting in pathological conditions or diseases such as ischemia-reperfusion injury, multi-organ dysfunction, stroke, infarction, or neurodegenerative diseases. This minireview outlines current ferroptosis-inducing anti-cancer strategies and highlights the detection as well as the therapeutic targeting of ferroptosis in preclinical experimental settings. Herein, we also briefly summarize observations related to LPO, iron and redox deregulation in patients that might hint towards ferroptosis as a contributing factor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisLipid PeroxidationNeoplasmsHumansAnimalsIronOxidation-ReductionAntineoplastic AgentsReperfusion InjuryNeurodegenerative Diseases

Stichwörter der Autor:innen

cancercell deathferroptosisischaemia-reperfusion injurylipid peroxidationoxidative stress

Substanzen

IronAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • VIB-UGent Center for Inflammation Research, Ghent, Belgium.
  • Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.

ORCID-Profile: Tom Vanden Berghe

Zitieren

APA

Walravens, M., Koeken, I., & Vanden Berghe, T. (2024). Therapeutic exploitation of ferroptosis. Biochemical Society Transactions. https://doi.org/10.1042/bst20230550

Vancouver

Walravens M, Koeken I, Vanden Berghe T. Therapeutic exploitation of ferroptosis. Biochemical Society Transactions. 2024. doi:10.1042/bst20230550

BibTeX
@article{Walravens2024,
  author = {Walravens, Magali and Koeken, Ine and Vanden Berghe, Tom},
  title = {Therapeutic exploitation of ferroptosis},
  journal = {Biochemical Society Transactions},
  year = {2024},
  doi = {10.1042/bst20230550}
}
Kostenlos starten →